Get access to our best features

Get access to our best features

Published 1 year ago

Pfizer’s COVID cash powers a ‘marketing machine’ on the hunt for new supernovas

Summary by Ground News

Pfizer has reaped nearly $100 billion from selling COVID-19 vaccines and treatments to U.S. taxpayers and foreign governments. With that windfall, it plans to get richer, sinking the cash into developing and marketing potential blockbusters for conditions like migraines, ulcerative colitis, prostate cancer and obesity.

0 Articles

0 Articles

All

Left

Center

Right

The Perfect Enemy

Pfizer’s COVID cash powers a ‘marketing machine’ on the hunt for new supernovas

Pfizer’s COVID cash powers a ‘marketing machine’ on the hunt for new supernovas The Philadelphia Inquirer…

Read Full Article

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/year

Stories disproportionately reported by the Left or the Right

Ground News Article Assistant

Not enough coverage to generate an Article Assistant.

Coverage Details

Total News Sources0

Leaning Left0Leaning Right0Center0Last Updated1 year agoBias Distribution

No sources with tracked biases.

Bias Distribution

There is no tracked Bias information for the sources covering this story.

Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Sources are mostly out of (0)

Similar News Topics

Stories disproportionately reported by the Left or the Right

Similar News Topics

Trending Topics

Donate Privacy Policy Manage Cookies Terms and Conditions

© 2024 Snapwise Inc.